These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23062821)

  • 21. Recognition of Smac-mimetic compounds by the BIR domain of cIAP1.
    Cossu F; Malvezzi F; Canevari G; Mastrangelo E; Lecis D; Delia D; Seneci P; Scolastico C; Bolognesi M; Milani M
    Protein Sci; 2010 Dec; 19(12):2418-29. PubMed ID: 20954235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
    Kulathila R; Vash B; Sage D; Cornell-Kennon S; Wright K; Koehn J; Stams T; Clark K; Price A
    Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):58-66. PubMed ID: 19153467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP.
    Sun H; Nikolovska-Coleska Z; Lu J; Meagher JL; Yang CY; Qiu S; Tomita Y; Ueda Y; Jiang S; Krajewski K; Roller PP; Stuckey JA; Wang S
    J Am Chem Soc; 2007 Dec; 129(49):15279-94. PubMed ID: 17999504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAP.
    Ardecky RJ; Welsh K; Finlay D; Lee PS; González-López M; Ganji SR; Ravanan P; Mace PD; Riedl SJ; Vuori K; Reed JC; Cosford ND
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4253-7. PubMed ID: 23743278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathways: targeting death receptors and smac mimetics.
    Fulda S
    Clin Cancer Res; 2014 Aug; 20(15):3915-20. PubMed ID: 24824309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smac mimetics as new cancer therapeutics.
    Chen DJ; Huerta S
    Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of aminopiperidine-based Smac mimetics as IAP antagonists.
    Hennessy EJ; Saeh JC; Sha L; MacIntyre T; Wang H; Larsen NA; Aquila BM; Ferguson AD; Laing NM; Omer CA
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1690-4. PubMed ID: 22264476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small molecule inhibitor of apoptosis proteins antagonists: a patent review.
    Hird AW; Aquila BM; Hennessy EJ; Vasbinder MM; Yang B
    Expert Opin Ther Pat; 2015 Jul; 25(7):755-74. PubMed ID: 25980951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting the inhibitors: retro-inverso Smac peptides.
    Hossbach J; Michalsky E; Henklein P; Jaeger M; Daniel PT; Preissner R
    Peptides; 2009 Dec; 30(12):2374-9. PubMed ID: 19682522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.
    Oost TK; Sun C; Armstrong RC; Al-Assaad AS; Betz SF; Deckwerth TL; Ding H; Elmore SW; Meadows RP; Olejniczak ET; Oleksijew A; Oltersdorf T; Rosenberg SH; Shoemaker AR; Tomaselli KJ; Zou H; Fesik SW
    J Med Chem; 2004 Aug; 47(18):4417-26. PubMed ID: 15317454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical basis for enhanced binding of peptide dimers to X-linked inhibitor of apoptosis protein.
    Splan KE; Allen JE; McLendon GL
    Biochemistry; 2007 Oct; 46(42):11938-44. PubMed ID: 17910418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.
    Liu Z; Sun C; Olejniczak ET; Meadows RP; Betz SF; Oost T; Herrmann J; Wu JC; Fesik SW
    Nature; 2000 Dec 21-28; 408(6815):1004-8. PubMed ID: 11140637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
    Ali R; Singh S; Haq W
    Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-molecule pan-IAP antagonists: a patent review.
    Flygare JA; Fairbrother WJ
    Expert Opin Ther Pat; 2010 Feb; 20(2):251-67. PubMed ID: 20100005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.
    Abhari BA; Davoodi J
    J Mol Biol; 2008 Sep; 381(3):645-54. PubMed ID: 18619610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational selection, dynamic restriction and the hydrophobic effect coupled to stabilization of the BIR3 domain of the human X-linked inhibitor of apoptosis protein by the tetrapeptide AVPI.
    de Souza TL; Sanches D; Gonçalves RB; da RochaPita SS; Pascutti PG; Bianconi ML; de Almeida FC; Silva JL; de Oliveira AC
    Biophys Chem; 2010 Nov; 152(1-3):99-108. PubMed ID: 20843595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, stereoselective synthesis, and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists.
    Asano M; Hashimoto K; Saito B; Shiokawa Z; Sumi H; Yabuki M; Yoshimatsu M; Aoyama K; Hamada T; Morishita N; Dougan DR; Mol CD; Yoshida S; Ishikawa T
    Bioorg Med Chem; 2013 Sep; 21(18):5725-37. PubMed ID: 23928071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy.
    Seneci P; Bianchi A; Battaglia C; Belvisi L; Bolognesi M; Caprini A; Cossu F; Franco Ed; Matteo Md; Delia D; Drago C; Khaled A; Lecis D; Manzoni L; Marizzoni M; Mastrangelo E; Milani M; Motto I; Moroni E; Potenza D; Rizzo V; Servida F; Turlizzi E; Varrone M; Vasile F; Scolastico C
    Bioorg Med Chem; 2009 Aug; 17(16):5834-56. PubMed ID: 19620011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based design and synthesis of tricyclic IAP (Inhibitors of Apoptosis Proteins) inhibitors.
    Hird AW; Aquila BM; Block MH; Hennessy EJ; Kamhi VM; Omer CA; Laing NM; Saeh JC; Sha L; Yang B
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1820-4. PubMed ID: 24631189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TwistDock workflow for evaluation of bivalent Smac mimetics targeting XIAP.
    Huang Q; Peng Y; Peng Y; Wei D; Wei Y; Feng S
    Drug Des Devel Ther; 2019; 13():1373-1388. PubMed ID: 31118573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.